NFKBIZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.683380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.298800E-01
Normal-vs-Stage2
1.718560E-01
Normal-vs-Stage3
4.385700E-02
Normal-vs-Stage4
7.016000E-02
Stage1-vs-Stage2
7.487200E-01
Stage1-vs-Stage3
5.348600E-01
Stage1-vs-Stage4
6.201600E-01
Stage2-vs-Stage3
5.225000E-01
Stage2-vs-Stage4
5.622400E-01
Stage3-vs-Stage4
9.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.682170E-01
Normal-vs-AfricanAmerican
1.308600E-01
Normal-vs-Asian
3.194000E-01
Caucasian-vs-AfricanAmerican
9.606400E-01
Caucasian-vs-Asian
6.405200E-01
AfricanAmerican-vs-Asian
7.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.280210E-01
Normal-vs-Female
2.382200E-01
Male-vs-Female
4.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.053770E-01
Normal-vs-Age(41-60Yrs)
3.172400E-01
Normal-vs-Age(61-80Yrs)
1.055380E-01
Normal-vs-Age(81-100Yrs)
3.425600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.363200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.352600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.973800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.507900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.985200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.718800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.582400E-01
Normal-vs-Daily Drinker
4.755800E-02
Normal-vs-Weekly Drinker
3.222300E-02
Normal-vs-Occasional Drinker
2.797400E-01
Normal-vs-Social Drinker
2.416800E-01
Non Drinker-vs-Daily Drinker
1.627790E-01
Non Drinker-vs-Weekly Drinker
2.414200E-01
Non Drinker-vs-Occasional Drinker
8.895400E-01
Non Drinker-vs-Social Drinker
9.619800E-01
Daily Drinker-vs-Weekly Drinker
9.427200E-01
Daily Drinker-vs-Occasional Drinker
2.845800E-01
Daily Drinker-vs-Social Drinker
1.886390E-01
Weekly Drinker-vs-Occasional Drinker
3.616000E-01
Weekly Drinker-vs-Social Drinker
2.337400E-01
Occasional Drinker-vs-Social Drinker
8.703200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.302400E-01
Normal-vs-Grade 2
2.434400E-02
Normal-vs-Grade 3
7.030500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.813200E-01
Grade 1-vs-Grade 3
2.949800E-01
Grade 1-vs-Grade 4
2.302400E-01
Grade 2-vs-Grade 3
9.469600E-01
Grade 2-vs-Grade 4
2.434400E-02
Grade 3-vs-Grade 4
7.030500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.458100E-02
Normal-vs-NonDiabetic
1.480580E-01
Diabetic-vs-NonDiabetic
3.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.201400E-01
Normal-vs-NoPancreatitis
8.262400E-02
Pancreatitis-vs-NoPancreatitis
2.652000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.840800E-01
Normal-vs-N1
1.329560E-01
N0-vs-N1
6.977800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.404840E-01
Normal-vs-TP53-NonMutant
2.628400E-01
TP53-Mutant-vs-TP53-NonMutant
7.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
